We invite researchers, clinicians, and academicians to contribute original research articles, review papers, and case studies to the upcoming issue of the Journal of Emerging Research in Cancer Pharmacotherapy (JERCP). The journal provides a dedicated platform for publishing high-quality, peer-reviewed work that advances the science and practice of cancer pharmacotherapy.
Focus Areas Include
- Pharmacological innovations in cancer therapy
- Chemotherapy protocols and resistance mechanisms
- Drug discovery and design for oncology
- Targeted therapy and precision oncology
- Pharmacogenomics in cancer treatment
- Novel drug delivery systems for anticancer agents
- Integrative pharmacotherapy in cancer care
- Preclinical and clinical pharmacokinetic/pharmacodynamic studies
Submission Guidelines
- Manuscripts should be prepared according to the Instructions for Authors provided on our website.
- Submissions should be original and not under consideration for publication elsewhere.
- All submissions are subject to a rigorous peer review process to ensure the highest quality and integrity of the content.
- Accepted papers will be published in upcoming issues of the journal.
Submission Process
To submit your manuscript:
- Online Submission: Please submit your manuscript through our [online submission system].
- Review Timeframe: You will receive a response within 2-3 working days, and your paper will be reviewed within 8 days.
- Notification: You will receive acceptance or rejection notification within 22 days of submission.
Contact Us
For queries related to submissions or the journal’s scope, please email us.
Join our mission to shape the future of cancer pharmacotherapy research.
